Company / Return on Assets (ROA)
Jazz Pharmaceuticals Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-3.0%
FY2025
5-year range
-3.0% / 4.7%
FY2021-FY2025
Trend
-165.5%
vs FY2024
Sector context
#69 of 213
Health Care
What the data says
At -3.0%, Jazz Pharmaceuticals's return on assets (roa) ranks #69 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -3.0% in FY2025 to 9.5% in FY2017.
Based on SEC 10-K filings.
-3.0% in FY2025 with a 5-year CAGR of -9.9%.
Declined from 3.6% to -3.0% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -5.3pp
- 5-Year Change
- -9.9pp
- 10-Year Change
- -
Sector benchmark
#69 of 213 in Health CareTop 32% of 213This company -3.0% Sector average -24.2%
▼
+87.4% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 165.5% year-over-year.
- Currently 21.1pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3.0% | -165.5% |
| FY2024 | 4.7% | +28.0% |
| FY2023 | 3.6% | +65.5% |
| FY2022 | 2.2% | -48.4% |
| FY2021 | 4.3% | -37.7% |
| FY2020 | 6.8% | -22.4% |
| FY2019 | 8.8% | +15.5% |
| FY2018 | 7.6% | -19.9% |
| FY2017 | 9.5% | +680.3% |
| FY2016 | 1.2% | -87.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026